Skip to main content

Table 2 Patient medications and co-morbidities

From: Cholinergic Anti-Inflammatory Pathway Activity and High Mobility Group Box-1 (HMGB1) Serum Levels in Patients with Rheumatoid Arthritis

  

ACR

Duration of

  

Gender

Age

Criteria

RA (years)

Smoking

RA Tx

M/F=4/9

Avg = 52.7 Median=52

    

F

54

Y

4

n

Sulfasalazine

F

63

Y

5

n

TNF-alpha blocker

F

47

Y

10

n

TNF-alpha blocker p ]Methotrexate Prednisone

F

55

Y

6

n

TNF-alpha blocker Methotrexate Folic Acid

F

52

Y

17

n

TNF-alpha blocker Methotrexate Folic Acid Hydroxychloroquine NSAIDS

F

38

Y

3

n

Hydroxychloroquine

M

51

Y

16

n

TNF-alpha blocker Prednisone

F

58

Y

10

n

Hydroxychloroquine Prednisone

M

46

Y

16

n

TNF-alpha blocker Methotrexate Folic Acid Prednisone

F

38

Y

10

n

Methotrexate Prednisone NSAIDs

F

32

Y

5

n

Sulfasalazine Methotrexate Folic Acid Prednisone

M

70

Y

31

n

TNF-alpha blocker Methotrexate Folic Acid Prednisone

M

82

Y

3

n

NSAIDs